RxDoctor Payments Data

Neha Prakash, MD

Neurology · Farmington, CTNPI 1891135000

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 92.9% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for neurology clinicians in CT, where the typical reported total is $893.

$1,247in general payments, 2019–2025

Across 7 payments — averaging $178.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Medtronic$88
$247,878in research payments, 2019–2025

Across 6 payments — averaging $41,313 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB SA$248K

What the payments were for

  • Travel & lodging$63251%
  • Food & beverage$61549%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific6$1,159
Medtronic1$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,247 in reported general payments places this provider in the 50th percentile of 280 neurology providers in Connecticut.

See all neurology providers in Connecticut

Medicare billing

Part B allowed, 2024
$93,344
Medicare patients
156
Services billed
5,940

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine24$123,297
IngrezzaValbenazine Tosylate13$100,882
Carbidopa-LevodopaCarbidopa/Levodopa285$7,796
Carbidopa20$4,326
Ropinirole ErRopinirole Hcl22$3,308
Propranolol Hcl ErPropranolol Hcl48$2,122
Carbidopa-Levodopa ErCarbidopa/Levodopa69$1,749
AmantadineAmantadine Hcl22$1,510
Donepezil Hcl114$1,474
Trihexyphenidyl Hcl57$1,239
Gabapentin57$1,228
Midodrine Hcl21$965
Memantine Hcl33$808
Atropine Sulfate12$705
Primidone29$532

Paid to pharmacies, not to this prescriber.

Other neurology in Farmington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →